TrialAmerican journal of respiratory and critical care medicine2011

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.